Cargando…
Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is caused by a dysregulated immune response against normal components of the intestinal microflora combined with defective functioning of anti-inflammatory pathways. Currently, all therapies approved for IBD manipulate the immune system by inhibiting pro-inflammatory...
Autores principales: | Giuffrida, Paolo, Cococcia, Sara, Delliponti, Mariangela, Lenti, Marco Vincenzo, Di Sabatino, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562982/ https://www.ncbi.nlm.nih.gov/pubmed/31052214 http://dx.doi.org/10.3390/cells8050397 |
Ejemplares similares
-
Validation of the Italian translation of the perceived stigma scale and resilience assessment in inflammatory bowel disease patients
por: Cococcia, Sara, et al.
Publicado: (2021) -
Stigmatisation and resilience in inflammatory bowel disease
por: Lenti, Marco Vincenzo, et al.
Publicado: (2019) -
Preventing Infections by Encapsulated Bacteria Through Vaccine Prophylaxis in Inflammatory Bowel Disease
por: Lenti, Marco Vincenzo, et al.
Publicado: (2020) -
Liver-spleen axis dysfunction in COVID-19
por: Cococcia, Sara, et al.
Publicado: (2021) -
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy
por: Lenti, Marco Vincenzo, et al.
Publicado: (2020)